- Uburyo bwo kuvura
- Ubuhamya
- Neuroblastoma
- Indwara ikomeye
- Ubuhamya
- TILS
- Ubuvuzi bwa Selile za NK
- Myasthenia Gravis (MG)
- Leukemia ikabije ya Lymphoblastic (B-ALL)
- Indwara ya Lupus Erythematosus yo mu mubiri (SLE)
- Leukemia ikabije ya Lymphoblastic (T-ALL)
- Lymphoma itari iya Hodgkin (NHL)
- Myeloma nyinshi (MM)
- Lymphom nini ya B-cell ikwirakwira
- Leukemia ya B-lymphocytic
- Myeloma
Umugabo w’intwari ukomoka mu Buhinde arwana na kanseri y’igifu
Hari umugabo w’intwari witwa Thirandas Shiva Prasad. Afite imyaka 32, kandi akomoka mu Buhinde. Kuki dushimangira ubushake bwe? Dore inkuru ye itangaje.
Thirandas yasanzwemo kanseri y'igifu mu 2023, ababara mu nda kandi byemejwe ko ari adenocarcinoma yo mu gifu yo mu rwego rwo hasi. Yakorewe imiti ya kanseri yo mu gifu ikoresheje FLOT regimen, hakurikiraho kubagwa harimo no kubagwa gastrectomy. Nubwo yavuwe nyuma yo kubagwa, kanseri yongeye kugaruka hamwe na metastases mu kibuno, bimutera ingorane nka hydronephrosis, abscesses, no kuziba. Yahuye n'ibipimo byinshi, birimo dialysis, stenting, n'ibindi bipimo bya kanseri hamwe na nab-paclitaxel, nivolumab, irinotecan, n'ibindi. Mu 2025, PET-CT scans yagaragaje ko yarushijeho kwiyongera hamwe n'ibisebe byo mu gifu na ascites, bituma akeneye uburyo bushya bwo kuvura.
Ashaka ubuvuzi bugezweho, Thirandas yerekeje kuri BIOOCUS. Itsinda ryacu ry'inzobere ryatanze isuzuma rya mbere ku buntu, risuzuma amateka ye menshi kandi rinamugira inama yo kuvura selile za CLDN18.2 CAR-T, zijyanye n'imiterere y'ikibyimba cye. Nyuma yo kuvura mbere y'uko akira, guterwa kwakozwe neza mu kigo cyacu cyateye imbere. Nubwo hari ibibazo bya mbere nko kugira umuriro n'ibyashoboraga kwandura, itsinda ryacu ry'abahanga mu nzego zitandukanye ryabashije kuvura ibimenyetso neza rikoresheje imiti yica udukoko n'ubuvuzi bufasha, rigenzura ko nta CRS ikomeye yabayeho. Uburyo nko gusohora amazi mu nda no gukosora stent bwakozwe neza, bigatuma ibimenyetso bigabanuka kandi indwara zigakira nyuma yo kuvurwa.
BIOOCUS irazwiho gutanga serivisi nziza cyane n'ibicuruzwa bishya. Ubuvuzi bwacu bwa CAR-T, bugamije CLDN18.2, butanga igitero cyihariye ku tunyangingo twa kanseri, akenshi bugatsinda aho ubuvuzi busanzwe bwananiranye. Serivisi z'abarwayi ni nziza mu guhuza ingendo mpuzamahanga, gutanga ubushishozi ku muco, no gutanga ikurikiranwa ryuzuye, byose nta mananiza menshi. Thirandas yishimira abakozi b'impuhwe n'inzira nziza zahinduye uburambe buteye ubwoba bukaba icy'icyizere.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

